Hypothetical protein CICLE_v10011260mg, Tangerine Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-Hypothetical protein CICLE_v10011260mg, Tangerine antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Hypothetical protein CICLE_v10011260mg, Tangerine |
| Clone | monoclonal |
| Host Species | Mouse |
| Reactive Species | tangerine |
| Isotype | IgG |
| Format | unconjugated |
| Size | 0.1 mL |
| Concentration | n/a |
| Applications | Western Blot (WB) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This gene encodes a subunit of mitochondrial ATP synthase. Mitochondrial ATP synthase catalyzes ATP synthesis, using an electrochemical gradient of protons across the inner membrane during oxidative phosphorylation. ATP synthase is composed of two linked multi-subunit complexes: the soluble catalytic core, F1, and the membrane-spanning component, Fo, comprising the proton channel. The catalytic portion of mitochondrial ATP synthase consists of 5 different subunits (alpha, beta, gamma, delta, and epsilon) assembled with a stoichiometry of 3 alpha, 3 beta, and a single representative of the other 3. The proton channel consists of three main subunits (a, b, c). This gene encodes the alpha subunit of the catalytic core. Alternatively spliced tr |
| Immunogen | Source Note: This monoclonal antibody is produced by immunizing mice with a polypeptide corresponding to hypthetical protein CICLE_v10011260mg protein. |
| Other Names | n/a |
| Gene, Accession # | [CICLE] |
| Catalog # | MBS435361 |
| Price | $495 |
| Order / More Info | Hypothetical protein CICLE_v10011260mg, Tangerine Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies